BioSpace News Archive

Geo-Med & Xenex Enhance Veteran Safety with Infection Prevention Programs Utilizing LightStrike Germ-Zapping Robots

Introduction in the US of Cyspera, a breakthrough topical solution for stubborn skin discoloration, through a new partnership between Scientis, the Swiss original brand manufacturer, and SENTÉ, a specialty aesthetics company

Reed Technology and Information Services Inc. (Reed Tech), a leading provider of data management and analytics solutions for the life sciences industry, and 1WorldSync™, the leading provider of product content solutions, have expanded their collaboration to include a full-service solution for medical device manufacturers to manage regulatory and commercial product information, including UDI (Unique Device Identifier) submissions to EUDAMED (European Union Databank on Medical Devices).

ClearLight Biotechnologies, LLC announced today the execution of an exclusive world-wide license agreement to develop and commercialize the 3D tissue clearing technology, CRYSTAL, invented by Professor Adriano Aguzzi, M.D, Ph.D., and Daniel Kirschenbaum, M.D, Ph.D. at the University of Zurich and the University Hospital Zurich.

Abbott announced that new research, published in the journal Circulation, found its algorithm could help doctors in hospital emergency rooms more accurately determine if someone is having a heart attack or not, so that they can receive faster treatments or be safely discharged.

The company has recently added industry experts from the medical and gaming industries to its team, including Dr. James Petros, Chief Medical Officer, and Andy Riedel, Chief Technology Officer.

MMS Holdings – an award-winning, data-focused CRO – was recently announced as an honorable mention recipient of PR Daily’s Corporate Social Responsibility Awards in the Engagement & Communications category for its #OneMMS volunteer campaign.

The Phase I, open-label, dose escalation trial in China is designed to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of intraperitoneally administered SCB-313 as a single-agent for the treatment of peritoneal carcinomatosis.

The global urine flow meters market size is poised to reach USD 22.92 million by 2023, according to a new report by Technavio, progressing at a CAGR of over 6% during the forecast period.

Partnership will enable prescription, dispensation and reimbursement of Cognoa’s behavioral health products